dc.creatorPEREIRA, Rosa Maria Rodrigues
dc.creatorCARVALHO, Jozelio Freire de
dc.creatorBONFA, Eloisa
dc.date.accessioned2012-10-19T17:08:22Z
dc.date.accessioned2018-07-04T15:05:11Z
dc.date.available2012-10-19T17:08:22Z
dc.date.available2018-07-04T15:05:11Z
dc.date.created2012-10-19T17:08:22Z
dc.date.issued2009
dc.identifierAUTOIMMUNITY REVIEWS, v.8, n.5, p.415-419, 2009
dc.identifier1568-9972
dc.identifierhttp://producao.usp.br/handle/BDPI/21608
dc.identifier10.1016/j.autrev.2009.01.001
dc.identifierhttp://dx.doi.org/10.1016/j.autrev.2009.01.001
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1618382
dc.description.abstractMetabolic syndrome is characterized by a combination of various cardiovascular risk factors (age, gender, smoking, hypertension and dyslipidemia) that imply additional cardiovascular morbidity that is greater than the sum of the risks associated with each individual component. Herein, the authors review the rheumatological diseases in which metabolic syndrome has been studied: gout, osteoarthritis, systemic lupus erythematosus, rheumatoid arthritis, Sjogren`s syndrome and ankylosing spondylitis. The prevalence of metabolic syndrome in these disorders varies from 14% to 62.8%. The great majority of these studies demonstrated that this frequency was higher in rheumatological diseases than in the control populations, suggesting that either the presence or the treatment of those diseases seems to influence the risk of developing metabolic syndrome. (C) 2009 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherELSEVIER SCIENCE BV
dc.relationAutoimmunity Reviews
dc.rightsCopyright ELSEVIER SCIENCE BV
dc.rightsrestrictedAccess
dc.subjectMetabolic syndrome
dc.subjectRheumatoid arthritis
dc.subjectSystemic lupus erythematosus
dc.subjectGout
dc.subjectOsteoarthritis
dc.subjectAnkylosing spondylitis
dc.subjectSjogren`s syndrome
dc.titleMetabolic syndrome in rheumatological diseases
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución